
The Future of Medicine Shaped
by Cutting-Edge Cell Design Technology
The Research Institute for Cell Design Medical Science (RICeD) aims to become an international research and development center that successively creates seeds for the next-generation cell and gene therapies, through innovative cell design technologies, which are core strength of Yamaguchi University. RICeD also aims to promote the practical application of cutting-edge immunotherapy and genome medicine based on our innovative technologies, to develop treatments for intractable diseases such as cancer and genetic diseases, and to apply and verify these innovative therapies in companion animals. By creating an active cycle in which knowledge gained in humans and companion animals is fed back to each other, RICeD will endeavor to form a drug discovery ecosystem through the social implementation of the created technologies, contribute to local communities and foster human resources through the creation of industries, and extend the healthy lifespan of both humans and companion animals.
- ALL
- News
- Thesis
- Recruiting

News
2025.08.07
*Notice* Participating in the Osaka-Kansai Expo

News
2025.08.05
*Notice* Yamaguchi University-launched venture Noile-Immune Biotech Co., Ltd. aims to establish a research and development collaboration center for PRIME CAR-T cells in partnership with Yamaguchi University ~From Ube City to the world~

News
2025.08.01
*Announcement* Adopters of the RICeD x Crossover Project have been selected.

News
2025.07.15
*Notice* We exhibited at Regenerative Medicine EXPO 2025 Tokyo

News
2025.07.08
*Report* International Seminar (Division of Advanced Genome Editing Therapy) was held

News
2025.06.24
*Information* International Seminar will be held on Monday, July 7

News
2025.06.19
*Report* Seminar (Division of Advanced Cell Therapy) was held.
.png)
News
2025.06.18
*Report* Joint Seminar with the Division of Systems Medicine and Informatics

Thesis
2025.07.30
The future of Kawasaki disease management: data-driven innovations from bedside to bench and back again

Thesis
2025.07.28
Unsupervised identification of asthma symptom subtypes supports treatable traits approach

Thesis
2025.07.24
Wound-healing effects of frozen-thawed allogeneic fibroblast sheet transplantation and xenogeneic fibroblast cell sheet transplantation cultured on a new substrate/Development of Frozen-thawed Allogeneic Fibroblast Sheets for Esophageal Anastomotic Leakage

Thesis
2025.07.18
High-Concentration Hydrogen Delivery During Dialysis Using an Innovative Direct Dissolution Technique: In Vivo Kinetics in a Canine Model.

Thesis
2025.06.12
Riboflavin transporter: Evidence of a role as entry receptor for chimpanzee endogenous retrovirus

Thesis
2025.06.06
Single bolus injection of nicotinamide mono nucleotide increases systemic insulin sensitivity in association with activation of NAD salvage pathway in the liver and adipose tissue in mice

Thesis
2025.06.05
MXene-Integrated Contact Lens: A Breakthrough in Wearable Eye Protection and Healthcare.

Thesis
2025.05.22
Small nuclear ribonucleoprotein autoantibody associated with blood-nerve barrier breakdown in Guillain-Barré syndrome
The article could not be found.

News
2025.08.07
*Notice* Participating in the Osaka-Kansai Expo

News
2025.08.05
*Notice* Yamaguchi University-launched venture Noile-Immune Biotech Co., Ltd. aims to establish a research and development collaboration center for PRIME CAR-T cells in partnership with Yamaguchi University ~From Ube City to the world~

News
2025.08.01
*Announcement* Adopters of the RICeD x Crossover Project have been selected.

Thesis
2025.07.30
The future of Kawasaki disease management: data-driven innovations from bedside to bench and back again

Thesis
2025.07.28
Unsupervised identification of asthma symptom subtypes supports treatable traits approach

Thesis
2025.07.24
Wound-healing effects of frozen-thawed allogeneic fibroblast sheet transplantation and xenogeneic fibroblast cell sheet transplantation cultured on a new substrate/Development of Frozen-thawed Allogeneic Fibroblast Sheets for Esophageal Anastomotic Leakage

Thesis
2025.07.18
High-Concentration Hydrogen Delivery During Dialysis Using an Innovative Direct Dissolution Technique: In Vivo Kinetics in a Canine Model.

News
2025.07.15
*Notice* We exhibited at Regenerative Medicine EXPO 2025 Tokyo
About RICeD
Request for Donations to RICeD
We are promoting the development of cutting-edge cancer immunotherapy to cure many patients.
We are also working to extend the healthy lifespan of both humans and companion animals by applying the world’s first genome editing technology to the treatment of genetic diseases in companion animals and applying the results to human medicine,
We are also working to extend the healthy lifespan of both humans and companion animals by applying the results of our research to human medicine.We sincerely ask for your support to achieve these goals and to continue to promote the practical application of our research results in society.
ー Follow us! ー